GlaxoSmithKline Latvia, SIA

Historical data
Basic data
Name GlaxoSmithKline Latvia SIA
Legal form Limited liability company (SIA)
Registration number, date 40003633032, 03.06.2003
Register, Included in The Register Commercial register, 03.06.2003
SEPA identifier LV21ZZZ40003633032
Data from the VAT Register
VAT identification number Status Registered Excluded
LV40003633032 Isn't active 13.11.200308.06.2022
Check in EU VAT register
Legal address Legal address: Rīga, Duntes iela 3, LV-1013 Previous addresses
Other registered in this address
Postal address Duntes iela 3, Rīga, LV-1013
Liquidated 08.06.2022
Registration certificate number, date Nr. C12066. 03.06.2003
Fixed capital Paid capital - 5 989 578.00 EUR (Registered in State Enterprise register 25.05.2016)
Registered capital - 5 989 578.00 EUR (Registered in State Enterprise register 25.05.2016)
Activity code (NACE)
  • Wholesale of pharmaceutical goods (46.46, version 2.0) (Source: SRS, CSB, ZO.LV)
Data updated in the Register of Enterprises 08.06.2022
Financial indicators (last submitted year)
Year (last submitted) Sign in
Sign in
Turnover
Profit after taxes
Liquidity
Profitability (return on assets)
Number of employees
Annual reports (23)
Tax payments to state budget
(thous. EUR)
Year Total payments to state budget Personal income tax State mandatory social insurance contributions
2021 Sign in
2020
Sign in

Actual data

Actual data. List of procurations (0)
Actual data. List of beneficial owners (0)
Awards
  • SRS In-depth Cooperation Programme. BRONZE LEVEL <br>Since January 1, 2019, SRS has launched an expanded model of the In-depth Cooperation Programme. All participating taxpayers have been divided into three levels, depending on their extent of operations (Gold, Silver, Bronze)</br>; 2022. year 
    2022. year
  • TOP 500 major companies in Latvia by net turnover; 2018., 2019., 2020., 2021. year 
    2018., 2019., 2020., 2021. year
  • SRS In-depth Cooperation Programme. SILVER LEVEL <br>Since January 1, 2019, SRS has launched an expanded model of the In-depth Cooperation Programme. All participating taxpayers have been divided into three levels, depending on their extent of operations (Gold, Silver, Bronze)</br>; 2020. year 
    2020. year
  • SRS In-depth Cooperation Programme. GOLD LEVEL <br>Since January 1, 2019, SRS has launched an expanded model of the In-depth Cooperation Programme. All participating taxpayers have been divided into three levels, depending on their extent of operations (Gold, Silver, Bronze)</br>; 2019., 2020., 2021. year 
    2019., 2020., 2021. year
Comparative indices (2021 year)
Index Place
Net turnover
There are no data of the place of the previous year
  1013 , Major
There are no data of the place of the previous year
 1013 		Major
Profit or loss
There are no data of the place of the previous year
  2545
There are no data of the place of the previous year
 2545
Equity capital
There are no data of the place of the previous year
  821
There are no data of the place of the previous year
 821
Fixed assets
There are no data of the place of the previous year
  69579 - 115594
There are no data of the place of the previous year
 69579 - 115594
Balance
There are no data of the place of the previous year
  1654
There are no data of the place of the previous year
 1654
Tangible assets
There are no data of the place of the previous year
  65351 - 115595
There are no data of the place of the previous year
 65351 - 115595
Liquidity
There are no data of the place of the previous year
  4010 , Companies
There are no data of the place of the previous year
 4010 		Companies
Profitability
There are no data of the place of the previous year
  58215 , Companies
There are no data of the place of the previous year
 58215 		Companies
Registered capital * 209
 209

About the company's comparative indices

GlaxoSmithKline Latvia mentioned in newspapers   GlaxoSmithKline Latvia zo.lv catalogue
Legal address on the map
GlaxoSmithKline Latvia Legal address on the map
Publications (6)
Likvidēs “GlaxoSmithKline Latvia” 23.12.2021 06:14

Lursoft Klientu Portfeļa monitorings ziņo, ka, balstoties uz vienīgā dalībnieka lēmumu, š.g. 22. decembrī uzsākts SIA “GlaxoSmithKline Latvia” likvidācijas process

Read more
Farmaceitisko preču vairumtirgotājam “GlaxoSmithKline Latvia” izmaiņas valdē 09.02.2021 06:48

Lursoft dati rāda, ka vakar reģistrētas izmaiņas SIA “GlaxoSmithKline Latvia” valdes sastāvā. Priekšsēdētāja amatu uzņēmuma valdē saglabājis Georges Dagher, bet valdes locekles amatu turpinās ieņem Daina Dzirkale

Read more
“GlaxoSmithKline Latvia” pērn zemākā peļņa kopš 2007.gada 13.10.2020 06:26

Farmaceitisko produktu vairumtirgotājs SIA “GlaxoSmithKline Latvia” apgrozījums pērn, salīdzinot ar gadu iepriekš, palielinājies par 8,60%, sasniedzot 17,19 milj. EUR, lai gan peļņa būtiski samazinājusies.

Read more
“GlaxoSmithKline Latvia” iecelts jauns valdes priekšsēdētājs 30.09.2019 06:50

Zāļu vairumtirgotāja SIA “GlaxoSmithKline Latvia” līdzšinējais valdes priekšsēdētājs Nils Alexander Holler atstājis amatā, un viņa vietā par valdes priekšsēdētāju iecelts Georges Dagher, ziņo “Lursoft” Klientu portfelis.

Read more
“GlaxoSmithKline Latvia” valdē ieceļ jaunu locekli 18.07.2017 08:57

Zāļu vairumtirgotāja SIA “GlaxoSmithKline Latvia” valdē pirmdien, 17.jūlijā, iecelta jauna locekle - Daina Dzirkale, ziņo Klientu portfeļa monitorings.

Read more
Par Bērnu klīniskās universitātes slimnīcas valdes priekšsēdētāju iecelts Valts Ābols 29.03.2017 13:52

Par valsts SIA “Bērnu klīniskās universitātes slimnīca” valdes priekšsēdētāju pirmdien, 27.martā iecelts Valts Ābols, ziņo Klientu portfeļa monitorings.

Read more